Monte Rosa Therapeutics

About:

Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.

Website: https://www.monterosatx.com/

Twitter/X: MonteRosaTx

Top Investors: Cormorant Asset Management, Fidelity, Google Ventures, New Enterprise Associates, RTW Investments

Description:

Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways. Its rational approach in targeting disease-causing proteins for degradation will deliver pioneering therapies for cancer and beyond.

Total Funding Amount:

$349M

Headquarters Location:

Basel, Basel-Stadt, Switzerland

Founded Date:

2018-01-01

Contact Email:

info(AT)monterosatx.com

Founders:

Alexander Flohr

Number of Employees:

51-100

Last Funding Date:

2024-05-16

IPO Status:

Public

© 2025 bioDAO.ai